GlaxoSmithKline Pharma reports 2% YoY growth in revenue at Rs808cr

7 Feb 2022 , 04:45 PM

GlaxoSmithKline Pharmaceuticals Ltd. today declared its financial results for the quarter ended December 31, 2021. Company’s revenue for the quarter stood at Rs 808 crores recording a growth of 2% YoY against revenue of Rs 793.09 crore for the quarter ended December 2020. Revenue from Continuing Operations for the nine months ended December 31, 2021, was Rs 2,426 crores recording a growth of 11% YoY against Rs 2183 crore for the corresponding 9M period.

PBT (before exceptional items) from Continuing Operations for the quarter at Rs 189 crores recorded a growth of 6% YoY as compared to Rs 177 crores for Q3 FY’21. PBT (before exceptional items) for the nine months ended December 2021 at Rs 585 crores, as against Rs 460 crores for Q3 FY’21, recorded a growth of 27% YoY.

EBITDA from Continuing Operations for December 2021 quarter stood at Rs 197 crores, recording a growth of 8% YoY. EBITDA from Continuing Operations for the 9M period ended December 2021 stood at Rs 582 crores recording a growth of 31 %.

PAT for Q3 FY 22 stood at Rs 150 crore as compared to Rs 157 crore for Q3 FY’21, down by 4.45% YoY.

“Pharmaceuticals Limited, said, “GSK’s established pharma portfolio recorded strong double-digit growth, driven by our core legacy brands such as Ca/pol, Augmentin, and Ceftum. While our promoted brands grew, our vaccines business was impacted on account of the third wave of the pandemic. However, as this phase of the pandemic recedes and schools open up across the country, we are witnessing a steady uptake in vaccination. We also continue to invest in our brands and raise awareness amongst parents about more innovative vaccines from our portfolio,” commented Sridhar Venkatesh, Managing Director, GlaxoSmithKline over the company’s results.

Glaxosmithkline Pharma closed at Rs1,581, up by Rs7.80 or 0.50% from its previous closing of Rs1,573.20. The scrip opened at Rs1,581.15 and has touched an intraday high and low of Rs1,590.30 and Rs1,570.25 respectively.